Question and answer session from the CIRM governing board's Spotlight on Disease seminar on March 21, 2012 in Sacramento, California. The board heard from UC Davis researchers who are using…
This seminar, presented to the CIRM governing board on January 17th, 2012, provides a glimpse into a future of personalized medicine in which genomics, the study of genes and their…
Craig Venter, president and founder of the J. Craig Venter Institute, spoke to the California Institute for Regenerative Medicine governing board on January 17th, 2012, about the future of personalized…
This seminar, presented to the California Institute for Regenerative Medicine governing board on January 17th, 2012, provides a glimpse into a future of personalized medicine in which genomics, the study…
Four minute excerpt from the Spotlight on Genomics seminar presentation at the January 17th 2012 CIRM governing board meeting. The video features a conversation between Catriona Jamieson, director for stem…
CIRM has funded a $5.5 million Disease Team to develop a follow-on cardiac stem cell clinical trial that uses a patient's own heart stem cells to regenerate scarred tissue damaged…
On June 23, 2011, Yang Xu spoke to the CIRM governing board about research bottlenecks in induced pluripotent (iPS) stem cell biology. iPS cells are created from a person's own…
CIRM has funded a $9 million disease team to develop a more effective and safer bone marrow transplant to treat sickle cell disease. The team is led by Dr. Donald…
(Part 2 of 2) Nancy Rene, a patient advocate for the Sickle Cell Foundation of California, spoke to the CIRM Governing Board at the "Spotlight on Disease Team Awards: Stem…
Robert Klein, J.D. and Claire Pomeroy, M.D., M.B.A., gave the welcoming remarks for the "Spotlight on Cardiovascular Therapies," an educational event presented at the California Institute for Regenerative Medicine Governing…
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
